Advertisement
U.S. Markets open in 5 hrs 23 mins

Cytophage Technologies Ltd. (CYTO.V)

TSXV - TSXV Real Time Price. Currency in CAD
0.3300+0.0050 (+1.54%)
At close: 03:59PM EDT

Cytophage Technologies Ltd.

26 Henlow Bay
Winnipeg, MB R3Y1G4
Canada

https://cytophage.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 

Key Executives

NameTitlePayExercisedYear Born
Dr. Steven Theriault B.Sc., M.Sc., Ph.D.CEO, Chief Science Officer & Director350kN/AN/A
Mr. Julius John Kalcevich M.B.A.Chief Financial Officer225kN/A1975
Ms. Heather Medwick B.A.Chief Operating Officer200kN/AN/A
Mr. Michael Graham M.B.A.Chief Commercialization Officer225kN/A1977
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Cytophage Technologies Ltd., a biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada. It develops poultry health products under the AviPhage name; food safety products under the PhageFend name; bovine mastitis products under the BoviPhage name; and water-soluble solution for livestock producers under the FarmPhage name. The company is headquartered in Winnipeg, Canada.

Corporate Governance

Cytophage Technologies Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.